• Mubritinib Reveals OXPHOS Dependence in AML

  2026-08-23

  Baccelli et al. repositioned Mubritinib, also known as TAK 165, from a historical ERBB2 inhibitor to a mechanistically defined inhibitor of mitochondrial electron transport chain complex I in acute myeloid leukemia. Their chemical-genetic analysis shows that OXPHOS hyperactivity marks a substantial, chemotherapy-resistant AML subgroup that is selectively vulnerable to complex I inhibition while normal CD34⁺ cells and many chemotherapy-sensitive leukemias are comparatively resistant.

• DiscoveryProbe Natural Product Library Plus for HTS

  2026-08-22

  The DiscoveryProbe Natural Product Library Plus is a 1,655-compound natural product library for HTS and HCS workflows. Its pre-dissolved 10 mM DMSO format supports staged screening of cell-permeable bioactive compounds, including hypothesis-driven studies of parasite enzymes such as CpAdhE.

• Diethylmaleate for GST and Oxidative Stress Studies

  2026-08-21

  Diethylmaleate provides a practical chemical route to perturb glutathione-dependent defenses in insect, cellular, and toxicology workflows. Its strongest use-case is mechanistic comparison: pair GSH depletion and GST inhibition with ROS, antioxidant, apoptosis, and stressor-sensitivity readouts.

• CRISPR Disruption of scaRNA1 and U2 Pseudouridylation

  2026-08-21

  Gardner-Kay and colleagues used CRISPR-Cas9 editing to disrupt scaRNA1 in HEK293T cells and directly connect reduced U2 Ψ89 pseudouridylation with transcriptome-wide isoform changes. The study provides a mechanistic framework for understanding how defective guide-RNA-directed modification of spliceosomal RNA may influence RNA processing and developmental disease biology.

• AP20187: Chemical Inducer of Dimerization

  2026-08-20

  AP20187 enables small-molecule control of engineered signaling proteins, allowing researchers to tune conditional gene expression, hematopoietic output, and metabolic responses. This guide connects practical assay design with troubleshooting and with mechanistic lessons from 14-3-3 cancer biology without overstating the evidence.

• Amikacin Sulfate: From Uptake to Translation

  2026-08-20

  A translational framework for using Amikacin Sulfate to connect ribosomal mechanism, intracellular activity, granuloma-targeted delivery, and renal safety strategy in non-tuberculous mycobacterial research.

• GRA12: A Conserved Toxoplasma Virulence Factor

  2026-08-19

  A 2025 Nature Communications study used pooled in vivo CRISPR-Cas9 screens to identify parasite secreted proteins required across diverse Toxoplasma gondii strains and mouse backgrounds. GRA12 emerged as a broadly conserved acute-infection effector that helps preserve the parasitophorous vacuole and limit immune-associated host-cell necrosis.

• Hydroxychloroquine Sulfate: Research Workflow Guide

  2026-08-18

  Hydroxychloroquine Sulfate (SKU B4874) provides an aqueous-compatible research reagent for examining autophagy pathway modulation and toll-like receptor 7/9 signaling in autoimmune disease research. It is suited to short-term cell and animal workflows, but not to protocols requiring DMSO or ethanol solubility or prolonged storage of prepared solutions.

• AZD3463: A Mechanism-First Assay Framework

  2026-08-18

  AZD3463 is an ALK/IGF1R inhibitor that enables a layered approach to neuroblastoma mechanism studies. This article translates lessons from chemically defined iPSC differentiation into more reproducible target, pathway, phenotype, and combination assays.

• Flubendazole: Practical Autophagy Workflows

  2026-08-17

  Build more informative Flubendazole experiments by pairing autophagy readouts with time-resolved measures of growth inhibition and cell killing. This workflow emphasizes solvent handling, dose design, assay interpretation, and troubleshooting for cancer biology research and carefully bounded disease-model applications.

• Alcian Blue at pH 2.5: From Stain to Strategy

  2026-08-17

  A thought-leadership guide to using Alcian Blue and Nuclear Fast Red as a mechanistically informed readout for acid mucopolysaccharides, mucin-rich tissues, and chondrogenic differentiation. The article connects dye chemistry, experimental controls, biopsy-handling evidence, and translational assay strategy while defining the appropriate research-use boundaries.

• EZ Cap™ Firefly Luciferase mRNA: Assay Design

  2026-08-16

  EZ Cap™ Firefly Luciferase mRNA can serve as more than a luminous endpoint: it is a quantitative tool for separating delivery, translation, and biological response. This guide connects Cap1 mRNA design with lipid nanoparticle manufacturing variables to improve reporter assay interpretation.

• CX-5461: A Mechanism-Led Assay Strategy

  2026-08-15

  CX-5461 is an RNA polymerase I inhibitor that connects rRNA transcription stress with DNA damage, mitotic catastrophe, senescence, and autophagy. This article presents a mechanism-led framework for selecting assays, interpreting combination studies, and designing translational cancer research workflows.

• ECL Western Blotting Substrate: Practical Protocol

  2026-08-15

  ECL Western Blotting Substrate (SKU K2187) is a luminol-based horseradish peroxidase detection reagent for nonradioactive Western blot signal capture on X-ray film or CCD cameras. It is intended for HRP chemiluminescence, not fluorescent or radioisotopic detection, and prepared substrate should be used promptly rather than stored long term.

• FOXM1–ERα Networks in Female Lung Adenocarcinoma

  2026-08-14

  This study integrates public transcriptomic datasets, ceRNA-network analysis, immune profiling, and cellular experiments to investigate FOXM1 in female lung adenocarcinoma. Its most informative contribution is a cautiously validated connection among FOXM1, hsa-miR-204-5p, DGCR5, and estrogen receptor 1, while also identifying FOXM1 expression as a candidate marker of tumor behavior and immunotherapy-related status.

451 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page